“RNA is a fantastic platform, but it won’t solve everything, right?” said Kathrin Jansen, Pfizer’s recently retired head of vaccine R&D who first suggested that Bourla pursue an mRNA shot for Covid. “To think a single technology will solve all your problems — well, it never does.”
For Pfizer, mRNA is unlikely to be a panacea. Even if it hits its ambitious drug development targets, persuades people to keep getting Covid shots and introduces a groundbreaking new flu or shingles vaccine, it’ll still have the same competitors, pricing pressures and regulatory hurdles it faced before.
https://www.bloomberg.com/news/features/...-skeptical
For Pfizer, mRNA is unlikely to be a panacea. Even if it hits its ambitious drug development targets, persuades people to keep getting Covid shots and introduces a groundbreaking new flu or shingles vaccine, it’ll still have the same competitors, pricing pressures and regulatory hurdles it faced before.
https://www.bloomberg.com/news/features/...-skeptical